SBI-993
Modify Date: 2025-08-25 10:05:25
SBI-993 structure
|
Common Name | SBI-993 | ||
|---|---|---|---|---|
| CAS Number | 2073059-82-0 | Molecular Weight | 452.529 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C23H24N4O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of SBI-993SBI-993 is an analog of SBI-477 that shows improved potency and suitable pharmacokinetic properties for in vivo bioavailability; reduces Txnip and Arrdc4 expression to a degree similar to that seen with SBI-477 in human myotubes; reduces muscle and liver TAG levels, enhances insulin signaling, and improved glucose tolerance in mice fed a high-fat diet. |
| Name | SBI-993 |
|---|
| Description | SBI-993 is an analog of SBI-477 that shows improved potency and suitable pharmacokinetic properties for in vivo bioavailability; reduces Txnip and Arrdc4 expression to a degree similar to that seen with SBI-477 in human myotubes; reduces muscle and liver TAG levels, enhances insulin signaling, and improved glucose tolerance in mice fed a high-fat diet. |
|---|---|
| References | References 1. Ahn B, et al. J Clin Invest. 2016 Sep 1;126(9):3567-79. View Related Products by Target Other Targets |
| Molecular Formula | C23H24N4O4S |
|---|---|
| Molecular Weight | 452.529 |
| InChIKey | BMMQYFWEGRLMNT-UHFFFAOYSA-N |
| SMILES | COc1ccc(-c2csc(NC(=O)c3ccc(NCC(=O)N4CCOCC4)cc3)n2)cc1 |